Omicron variant of SARS-CoV-2, an epidemiologic assessment of pediatric oncology patients in the Bronx
© 2022 The Authors. Cancer Reports published by Wiley Periodicals LLC..
BACKGROUND: Children receiving cytotoxic therapy for cancer have increased risk of infection due to drug-induced neutropenia and are therefore treated empirically for bacteremia when febrile or ill-appearing. However, viral infections, which are not frequently life-threatening, are the most common etiology of febrile episodes and there has been increased effort to differentiate patients who may have a higher risk for adverse outcomes.
CASE: We performed a retrospective chart review of pediatric oncology patients diagnosed with COVID-19 between December 20, 2021 and February 22, 2022 during the Omicron (B.1.1.529) surge at The Children's Hospital at Montefiore, a tertiary care center in the Bronx.
CONCLUSION: We found that no patients in our cohort developed respiratory distress, bacteremia, or serious illness after COVID-19 infection during the Omicron surge. Future studies will aid in understanding the relationship between community-acquired infections and bacteremia, and this knowledge can then be applied to develop optimal infection prevention clinical care guidelines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Cancer reports (Hoboken, N.J.) - 5(2022), 11 vom: 05. Nov., Seite e1724 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Offenbacher, Rachel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.11.2022 Date Revised 23.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/cnr2.1724 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347145515 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347145515 | ||
| 003 | DE-627 | ||
| 005 | 20231226033141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cnr2.1724 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347145515 | ||
| 035 | |a (NLM)36199156 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Offenbacher, Rachel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Omicron variant of SARS-CoV-2, an epidemiologic assessment of pediatric oncology patients in the Bronx |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.11.2022 | ||
| 500 | |a Date Revised 23.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Authors. Cancer Reports published by Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: Children receiving cytotoxic therapy for cancer have increased risk of infection due to drug-induced neutropenia and are therefore treated empirically for bacteremia when febrile or ill-appearing. However, viral infections, which are not frequently life-threatening, are the most common etiology of febrile episodes and there has been increased effort to differentiate patients who may have a higher risk for adverse outcomes | ||
| 520 | |a CASE: We performed a retrospective chart review of pediatric oncology patients diagnosed with COVID-19 between December 20, 2021 and February 22, 2022 during the Omicron (B.1.1.529) surge at The Children's Hospital at Montefiore, a tertiary care center in the Bronx | ||
| 520 | |a CONCLUSION: We found that no patients in our cohort developed respiratory distress, bacteremia, or serious illness after COVID-19 infection during the Omicron surge. Future studies will aid in understanding the relationship between community-acquired infections and bacteremia, and this knowledge can then be applied to develop optimal infection prevention clinical care guidelines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Sars-CoV2 | |
| 650 | 4 | |a bacteremia | |
| 650 | 4 | |a neutropenia | |
| 650 | 4 | |a omicron | |
| 700 | 1 | |a Gorlick, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Weiser, Daniel A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer reports (Hoboken, N.J.) |d 2018 |g 5(2022), 11 vom: 05. Nov., Seite e1724 |w (DE-627)NLM309522617 |x 2573-8348 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2022 |g number:11 |g day:05 |g month:11 |g pages:e1724 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cnr2.1724 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2022 |e 11 |b 05 |c 11 |h e1724 | ||